| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $399.0M | +49.6% |
| Cost of Revenue | $147.1M | +53.5% |
| R&D Expense | $234.5M | -11.8% |
| SG&A Expense | $298.7M | +6.1% |
| Operating Income | -$282.1M | +23.0% |
| Interest Expense | $2.3M | — |
| Pre-tax Income | -$257.1M | +23.2% |
| Income Tax | $0 | — |
| Net Income | -$257.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $449.7M | -43.1% |
| Short-term Investments | $330.0M | +1924.5% |
| Accounts Receivable | $85.2M | +43.9% |
| Inventory | $39.9M | -11.0% |
| Current Assets | $1.05B | +11.8% |
| Total Assets | $1.19B | +14.4% |
| Current Liabilities | $299.4M | +47.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$214.9M | -8.4% |
| Capital Expenditures | $5.7M | -21.6% |
| Investing Cash Flow | -$375.2M | -3381.7% |
| Financing Cash Flow | $349.9M | +5539.0% |
| Free Cash Flow | -$220.5M | -7.4% |
| +23.2% |
| EPS (Basic) | -$0.26 | +25.7% |
| EPS (Diluted) | -$0.26 | +25.7% |
| Total Liabilities |
| $344.9M |
| +43.6% |
| Stockholders' Equity | $840.9M | +5.6% |